Suppr超能文献

膜生物合成。可溶性嵌合多肽可作为大肠杆菌中突变型乳糖通透酶前体的证据。

Membrane biogenesis. Evidence that a soluble chimeric polypeptide can serve as a precursor of a mutant lac permease in Escherichia coli.

作者信息

Fried V A

出版信息

J Biol Chem. 1981 Jan 10;256(1):244-52.

PMID:7005212
Abstract

A mutant in the Escherichia coli lac permease, called Yf, appears to be defective in the biogenesis and proper assembly of this membrane protein. It was proposed that this defect led to the accumulation of a precursor of the mutant permease (Fried, V. A. (1977) J. Mol Biol. 114, 477-490). In this communication, evidence is presented that the lacYf mutant accumulates a novel lac-specific soluble polypeptide with a molecular weight of 87,000. Detected by double-label analysis on sodium dodecyl sulfate gels, and identified as a lac-specific polypeptide on a two-dimensional gel system, this polypeptide is immunoprecipitated by anti-transacetylase antibody. Pulse-chase experiments are consistent with the hypothesis that it is converted in vivo into a lac-specific membrane protein with an apparent molecular weight of 28,000, which appears to be the mutant lac permease. The results suggest that the 87,000-dalton soluble protein is a precursor of the mutant lac permease. It is proposed that this precursor is a polyprotein chimera containing both the lacY and lacA gene products.

摘要

大肠杆菌乳糖通透酶的一个突变体,称为Yf,似乎在这种膜蛋白的生物合成和正确组装方面存在缺陷。有人提出,这种缺陷导致了突变通透酶前体的积累(弗里德,V.A.(1977年)《分子生物学杂志》114卷,477 - 490页)。在本通讯中,有证据表明lacYf突变体积累了一种分子量为87,000的新型乳糖特异性可溶性多肽。通过十二烷基硫酸钠凝胶上的双标记分析检测到,并在二维凝胶系统上鉴定为乳糖特异性多肽,该多肽可被抗转乙酰酶抗体免疫沉淀。脉冲追踪实验与以下假设一致,即它在体内转化为一种表观分子量为28,000的乳糖特异性膜蛋白,该蛋白似乎是突变的乳糖通透酶。结果表明,87,000道尔顿的可溶性蛋白是突变乳糖通透酶的前体。有人提出,这种前体是一种包含lacY和lacA基因产物的多蛋白嵌合体。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验